| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11033-012-2071-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s11033-012-2071-4 |
| P698 | PubMed publication ID | 23054010 |
| P2093 | author name string | Yong-Bin Yang | |
| Yu-Rong Li | |||
| Yong-Chun Zhang | |||
| Hong-Bo Jin | |||
| Ying-Li Song | |||
| P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease | Q28189277 | ||
| Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action | Q28569709 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress | Q29615436 | ||
| Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials | Q33793020 | ||
| Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance | Q34598935 | ||
| Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms | Q34770666 | ||
| Lipoic acid: a multifunctional antioxidant | Q35191185 | ||
| Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway | Q35652010 | ||
| Why does diabetes mellitus increase the risk of cardiovascular disease? | Q36396621 | ||
| Lipoic acid attenuates high-fat-diet-induced oxidative stress and B-cell-related immune depression | Q38328009 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture | Q40361254 | ||
| MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway | Q40539177 | ||
| Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. | Q41981197 | ||
| A novel role for calpains in the endothelial dysfunction of hyperglycemia | Q42443607 | ||
| Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. | Q42466708 | ||
| Lipoic acid effects on established atherosclerosis | Q42716061 | ||
| Expression of superoxide dismutase and matrix metalloproteinase type 2 in diaphragm muscles of young rats. | Q43172533 | ||
| Vitamin E inhibits lipid peroxidation-induced adhesion molecule expression in endothelial cells and decreases soluble cell adhesion molecules in healthy subjects | Q44301920 | ||
| The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. | Q44333525 | ||
| Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide | Q44397510 | ||
| Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model | Q45124684 | ||
| Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study | Q45227732 | ||
| Diabetes induces endothelial dysfunction but does not increase neointimal formation in high-fat diet fed C57BL/6J mice. | Q46477612 | ||
| Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients | Q46690679 | ||
| Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase | Q46752076 | ||
| Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice | Q46833877 | ||
| Preactivated peripheral blood monocytes in patients with essential hypertension. | Q52978319 | ||
| Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice | Q58335892 | ||
| Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies | Q70400798 | ||
| Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy | Q78239362 | ||
| Effects of histamine 2 receptor antagonists on endothelial-neutrophil adhesion and surface expression of endothelial adhesion molecules induced by high glucose levels | Q79451917 | ||
| Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity | Q83534932 | ||
| General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid | Q83592593 | ||
| Cariporide inhibits high glucose-mediated adhesion of monocyte-endothelial cell and expression of intercellular adhesion molecule-1 | Q83831596 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 377-382 | |
| P577 | publication date | 2012-10-10 | |
| P1433 | published in | Molecular Biology Reports | Q15752755 |
| P1476 | title | Lipoic acid attenuates the expression of adhesion molecules by increasing endothelial nitric-oxide synthase activity | |
| P478 | volume | 40 |
| Q35091422 | Alpha-lipoic acid activates eNOS through activation of PI3-kinase/Akt signaling pathway |
| Q89896098 | Endothelial Nitric Oxide Mediates the Anti-Atherosclerotic Action of Torenia concolor Lindley var. Formosama Yamazaki |
| Q59136926 | Erythrocytic bioactivation of nitrite and its potentiation by far-red light |
| Q52722001 | Nitric oxide pathology and therapeutics in sickle cell disease. |
| Q33681568 | Potential therapeutic action of nitrite in sickle cell disease |
Search more.